Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Case of the Week

Section Editors: Matylda Machnowska1 and Anvita Pauranik2
1University of Toronto, Toronto, Ontario, Canada
2BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada

Sign up to receive an email alert when a new Case of the Week is posted.

Submit a Case Previous Cases ASPNR Pediatric Cases

April 8, 2021
  • Description
  • Legends
  • Companion Case
  • Companion Case Legends
  • Diagnosis
  • Brain Teaser
Loading

Cerebral Amyloid Angiopathy (CAA) Associated with Inflammation (Inflammatory CAA)

  • Background:
    • Cerebral amyloid angiopathy (CAA) is characterized by deposition of amyloid-beta in the media and adventitia of cortical and leptomeningeal arteries.
    • CAA can present on imaging as CAA (common), amyloidoma (uncommon), or inflammatory CAA (rare).
    • Two types of inflammatory responses are amyloid-beta-related angiitis (ABRA) ("an angiodestructive process characterized by a vasculitic transmural, often granulomatous, inflammatory infiltration") and CAA-related inflammation (CAA-RI) ("an inflammatory reaction that surrounds amyloid-laden vessels, without angiodestructive features"). In 2018, Corovic et al observed 73% ABRA, 51% CAA-RI, and 23% both subtypes in pathologic studies among 213 patients with inflammatory CAA.
  • Clinical Presentation:
    • While CAA often remains clinically occult, it most commonly presents with lobar intracerebral hemorrhage in an older normotensive patient when symptomatic.
    • The inflammatory form of CAA is much less frequently complicated by intracranial hemorrhage and patients can present with multiple nonspecific neurologic symptoms including subacute cognitive decline, seizures, and headaches.
    • Leptomeningeal disease with or without infiltrative white matter process is significantly more frequent in patients with ABRA and CAA-RI than those with CAA, whereas lobar hemorrhage is more frequent in patients with CAA.
    • Patients with CAA-RI and ABRA are generally younger than those with CAA, which is usually seen in patients older than 60.
  • Key Diagnostic Features:
    • MRI: Key imaging findings that distinguish typical CAA from CAA-RI and ABRA:
      • CAA: Lobar hemorrhages of different ages (best diagnostic clue); peripherally located cortical/subcortical microbleeds
      • CAA-RI and ABRA: Evolving and sometimes migratory areas of lobar white matter T2 prolongation or diffuse lobar edema; leptomeningeal enhancement (common); peripherally located tiny foci of cortical/subcortical microbleed and superficial siderosis; focal, masslike enhancement and intracerebral lobar hemorrhage (uncommon)
    • CSF analysis: In 2018, Corovic et al reported that 83% of patients with inflammatory CAA had an elevated protein of >45 mg/dL, 44% had an elevated CSF white cell count of >5 cells/mm3, and 17% had oligoclonal bands. Specific anti-amyloid-beta antibodies can be identified from the CSF of patients with biopsy-proven inflammatory CAA. These findings suggest an immune and humoral response being responsible for the findings of inflammatory CAA.
  • Differential Diagnoses:
    • Extrapontine osmotic demyelination: Areas of lobar T2 prolongation are usually bilateral and symmetric in cases of extrapontine osmotic demyelination. Associated electrolyte abnormalities characteristically with rapid correction of hyponatremia.
    • Posterior reversible encephalopathy syndrome (PRES): Areas of lobar T2 prolongation are usually bilateral and symmetric in cases of PRES, and it is often associated with known triggers including hypertension, and drug exposures.
    • Other types of vasculopathy/vasculitis: Often younger presentation; may be associated with areas of hemorrhage, infarction, and vascular abnormalities on angiographic imaging
    • Hypertensive vasculopathy (chronic hypertension): Generally central, deep gray matter, and brainstem microbleeds and chronic periventricular and deep white matter areas of T2 prolongation, which do not resolve over time
    • CVA: Expect restricted diffusion.
    • Sequelae of small vessel ischemic disease (leukoariosis): Not expected to resolve on short-term interval imaging
    • Toxic-metabolic or drug-related etiologies: Findings of areas of T2 prolongation are usually bilateral and symmetric in cases of toxic-metabolic or drug-related etiologies, and may be associated with relevant history of exposure.
    • CADASIL: Usually more extensive persistent white matter areas of T2 FLAIR hyperintense signal, involving the anterior temporal regions and external capsules preferentially
  • Treatment:
    • As ABRA or CAA-RI respond to immunosuppressive therapy, when neurologic and neuroradiologic findings are consistent with ABRA or CAA-RI, the physician should consider starting an appropriate immunosuppressive treatment even in the absence of pathologic confirmation.
    • If a biopsy is requested, the surgeon should direct the biopsy to the leptomeningeal and gray-white junction.

Suggested Reading

  1. Corovic A, Kelly S, Markus HS. Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke 2018;13:257–67
  2. Salvarani C, Morris JM, Giannini C, et al. Imaging findings of cerebral amyloid angiopathy, Aβ-related angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation: a single-institution 25-year experience. Medicine (Baltimore) 2016;95:e3613
  3. Salzman KL, Hamilton BE. Cerebral amyloid disease. Statdx.com
  4. Osborne AG. Cerebral amyloid disease, inflammatory. Statdx.com

Current Issue

American Journal of Neuroradiology: 46 (6)
American Journal of Neuroradiology
Vol. 46, Issue 6
1 Jun 2025
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Sign up for alerts
Advertisement

Case Collections

Clasic Case Archive
Case of the Week Archive
Case of the Month Archive
Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire